• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Peer-to-Peer E-Consults Save Money for Pediatric Trauma Patients

Medically reviewed by Carmen Pope, BPharm. Last updated on Nov 14, 2023.

By Lori Solomon HealthDay Reporter

TUESDAY, Nov. 14, 2023 -- Initial peer-to-peer e-consultations cost less than reflexive ambulance transfer in most situations for pediatric orthopedic trauma patients, according to a study published online Nov. 3 in the Journal of the American Academy of Orthopaedic Surgeons.

Arlene R. Maheu, from Thomas Jefferson University in Philadelphia, and colleagues modeled the expected costs of a formal peer-to-peer telemedicine intervention designed to triage pediatric orthopedic transfers. The analysis included 350 pediatric orthopedic trauma patients transferred to two in-network referral hospitals from outside facilities who were stratified into three groups: patients who required ambulance transfer, patients who required emergency department-level care but no ambulance transfer, and patients who did not require emergency department-level care.

The researchers found that the telemedicine triage strategy was cheaper than the transfer-all strategy ($4,858 versus $6,610). The telemedicine triage strategy remained cheaper than the transfer-all strategy across almost all possibilities for cost of a telemedicine visit and proportion of telemedicine-triaged patients. The analysis did not include additional potential benefits of triage before transfer, such as decreased length of time to completion of emergency department visit, cost to the family, and patient comfort and satisfaction. Additionally, the potential for misdiagnosis related to telehealth and its potential costs were not included.

"We revealed substantial cost savings for the health care system from implementing a telehealth platform for peer-to-peer consultation when considering patient transfer for musculoskeletal trauma," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted November 2023

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.